PF-Atlas › Clinical Trials › NCT04931147

A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers

RXC007 · Phase 1

Registry ID

NCT04931147

Phase

Phase 1

Status

Completed

Drug / intervention

RXC007

Sponsor

Redx Pharma Ltd

Start

2021-05-13

About this trial

RXC007 is evaluated in NCT04931147, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Redx Pharma Ltd. Current status: Completed.

View NCT04931147 on ClinicalTrials.gov →

Explore related

All RXC007 trials All IPF trials

Related trials

RXC007 — NCT05570058

Medical disclaimer. This page summarizes public trial data for NCT04931147 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.